Developmental therapeutics for inflammatory breast cancer: Biology and translational directions

Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer, which accounts for approximately 3% of cases of breast malignancies. Diagnosis relies largely on its clinical presentation, and despite a characteristic phenotype, underlying molecular mechanisms are poorly understood....

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Ricardo, Santa-Maria, Cesar A, Rossi, Giovanna, Carneiro, Benedito A, Chae, Young Kwang, Gradishar, William J, Giles, Francis J, Cristofanilli, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355355/
https://www.ncbi.nlm.nih.gov/pubmed/27926493
http://dx.doi.org/10.18632/oncotarget.13778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355355/
https://www.ncbi.nlm.nih.gov/pubmed/27926493
http://dx.doi.org/10.18632/oncotarget.13778

Ejemplares similares